CARLOS WILTZ: Open Payments
NPI 1205187747 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$667 in 30 payments from 15 companies in 2025. Trend: 2023 $724 · 2024 $600 · 2025 $667
Food & beverage: $667
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 6 | $157 |
| GENZYME CORPORATION | 7 | $154 |
| Galderma Laboratories, L.P. | 3 | $57 |
| Arcutis Biotherapeutics, Inc. | 2 | $48 |
| Amgen Inc. | 2 | $38 |
| Novartis Pharmaceuticals Corporation | 1 | $31 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $30 |
| LEO Pharma Inc. | 1 | $24 |
| KYOWA KIRIN, INC. | 1 | $24 |
| Journey Medical Corporation | 1 | $23 |
Products named: DUPIXENT, NEMLUVIO, Zoryve, OTEZLA, Rhapsido, BLU-U, ANZUPGO, POTELIGEO.
Industry payments across FL — which companies pay providers there.
